Ingredion (INGR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
18 Nov, 2025Executive summary
Q1 2025 net sales declined 4% year-over-year to $1,813M, mainly due to lower raw material costs, FX impacts, and the South Korea divestiture, but adjusted operating income rose 26% to $273M and reported operating income increased 30% to $276M, driven by improved mix, operational execution, and strong segment performance in Texture & Healthful Solutions and Food & Industrial Ingredients.
Gross profit margin expanded to 25.7%–26% from 22%–22.2% in Q1 2024, reflecting continued margin strength across segments.
Adjusted diluted EPS increased 43% to $2.97, while reported diluted EPS was $3.00, down from $3.23 due to one-time gains in the prior year.
Strong volume growth in Texture & Healthful Solutions (+7%) and overall volume up 3% excluding South Korea divestiture.
Operational excellence initiatives and cost savings are on track to meet or exceed a $50M run-rate target for 2025.
Financial highlights
Net sales for Q1 2025 were $1.8 billion, down 4% year-over-year; adjusted operating income was $273 million, up 26%; reported operating income was $276 million, up 30%.
Gross profit increased 12% to $466 million; gross margin up 350 basis points to 25.7%.
Adjusted EPS guidance for 2025 raised to $10.90–$11.60; reported EPS guidance at $10.93–$11.63.
Cash from operations was $77 million in Q1 2025, down from $209 million in Q1 2024, with full-year projection at $825–$950 million.
$55 million in share repurchases and $52 million in dividends paid YTD.
Outlook and guidance
Full-year 2025 guidance maintained for all segments, with expectations for sales volume growth and operating income improvement; net sales expected up low single digits, operating income up high teens (reported) and mid-single digits (adjusted).
Adjusted EPS guidance: $10.90–$11.60; effective tax rate expected at 26.0%–27.5%.
Cash from operations projected at $825–$950 million; capex expected at $400–$450 million.
Q2 2025 net sales expected to be flat to up low single digits; operating income flat to down low single digits due to tough comps.
Guidance reflects tariffs as of April 30, 2025; future changes not included.
Latest events from Ingredion
- Record 2025 results and clean label innovation drive strong growth and margin outlook.INGR
Consumer Analyst Group of New York Conference (CAGNY) 202617 Feb 2026 - Record 2025 EPS and margin growth led by Texture & Healthful Solutions and LATAM.INGR
Q4 20253 Feb 2026 - Q2 adjusted EPS up 24%, margins rose, and 2024 guidance increased despite lower sales.INGR
Q2 20242 Feb 2026 - Record Q3 profit, margin gains, and raised outlook driven by strong execution and cost savings.INGR
Q3 202416 Jan 2026 - Aiming for $3B sales by 2028 with 5%-6% CAGR, driven by innovation and premium texture solutions.INGR
Investor Update14 Jan 2026 - Record Q4 and 2024 EPS growth and margins set up further gains and investment in 2025.INGR
Q4 20248 Jan 2026 - Board seeks approval for director elections, executive pay, auditor ratification, and highlights ESG gains.INGR
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.INGR
Proxy Filing1 Dec 2025 - Strong 2024 results, new structure, and all proposals passed by majority vote.INGR
AGM 202521 Nov 2025